WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US

Following a similarly optimistic forecast from WuXi AppTec—and amid a national security-related controversy in the U.S.—Chinese contract developer and manufacturer WuXi Biologics is accentuating the positive.